Literature DB >> 16884978

Opioids and cardioprotection: the impact of morphine and fentanyl on recovery of ventricular function after cardiopulmonary bypass.

Glenn S Murphy1, Joseph W Szokol, Jesse H Marymont, Michael J Avram, Jeffery S Vender.   

Abstract

OBJECTIVES: Experimental studies have shown that opioids protect the myocardium from ischemic injury and that opioid cardioprotection is enhanced by the coadministration of volatile anesthetics. Previous data suggest that morphine produces a more potent cardioprotective effect than fentanyl. The present study investigated the effect of the choice of intraoperative opioid (morphine or fentanyl) on recovery of myocardial function after coronary artery bypass graft (CABG) surgery.
DESIGN: Prospective, randomized study.
SETTING: University hospital. PARTICIPANTS: Forty-six patients undergoing CABG surgery.
INTERVENTIONS: Patients were randomly assigned to receive either morphine (40 mg) or fentanyl (1,000 mug) before cardiopulmonary bypass (CPB). Global cardiac function was assessed intraoperatively using the myocardial performance index (MPI), which combines echocardiographic parameters of both systolic and diastolic function.
MEASUREMENTS AND MAIN RESULTS: The MPI (median [range]) was increased after CPB in the fentanyl group, indicating a significant worsening of global left ventricular function (0.43 [0.28-0.54] baseline; 0.49 [0.32-0.64] 15 minutes post-CPB; 0.51 [0.36-0.63] end of operation; p < 0.05 post-CPB compared with baseline). The MPI improved in the morphine group after CPB (0.44 [0.32-0.64] baseline; 0.36 [0.24-0.45] 15 minutes post-CPB; 0.34 [0.20-0.46] end of operation; p < 0.05 post-CPB compared with baseline and the fentanyl group).
CONCLUSIONS: In patients undergoing CPB, global ventricular function is enhanced by the administration of morphine prior to the ischemic insult of cardioplegic arrest.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16884978     DOI: 10.1053/j.jvca.2005.07.036

Source DB:  PubMed          Journal:  J Cardiothorac Vasc Anesth        ISSN: 1053-0770            Impact factor:   2.628


  16 in total

Review 1.  Endogenous opiates and behavior: 2006.

Authors:  Richard J Bodnar
Journal:  Peptides       Date:  2007-09-11       Impact factor: 3.750

Review 2.  Opioid-induced cardioprotection.

Authors:  Katsuya Tanaka; Judy R Kersten; Matthias L Riess
Journal:  Curr Pharm Des       Date:  2014       Impact factor: 3.116

Review 3.  Opioid receptors and cardioprotection - 'opioidergic conditioning' of the heart.

Authors:  John P Headrick; Louise E See Hoe; Eugene F Du Toit; Jason N Peart
Journal:  Br J Pharmacol       Date:  2015-02-27       Impact factor: 8.739

4.  Transient receptor potential vanilloid 1 inhibitors block laparotomy- and opioid-induced infarct size reduction in rats.

Authors:  Helen M Heymann; Yun Wu; Yao Lu; Nir Qvit; Garrett J Gross; Eric R Gross
Journal:  Br J Pharmacol       Date:  2017-11-21       Impact factor: 8.739

5.  Morphine enhances LPS-induced macrophage apoptosis through a PPARγ-dependent mechanism.

Authors:  Mingying Lin; Keqiong Deng; Ya Li; Jing Wan
Journal:  Exp Ther Med       Date:  2021-05-03       Impact factor: 2.447

6.  Global changes in the rat heart proteome induced by prolonged morphine treatment and withdrawal.

Authors:  Zdenka Drastichova; Jitka Skrabalova; Petr Jedelsky; Jan Neckar; Frantisek Kolar; Jiri Novotny
Journal:  PLoS One       Date:  2012-10-09       Impact factor: 3.240

7.  Prolonged morphine administration alters protein expression in the rat myocardium.

Authors:  Zdenka Drastichova; Jitka Skrabalova; Jan Neckar; Frantisek Kolar; Jiri Novotny
Journal:  J Biomed Sci       Date:  2011-11-30       Impact factor: 8.410

8.  Morphine and remifentanil-induced cardioprotection: its experimental and clinical outcomes.

Authors:  Jin Mo Kim; Young Ho Jang; Jun Kim
Journal:  Korean J Anesthesiol       Date:  2011-11-23

9.  Morphine Reduces Myocardial Infarct Size via Heat Shock Protein 90 in Rodents.

Authors:  Bryce A Small; Yao Lu; Anna K Hsu; Garrett J Gross; Eric R Gross
Journal:  Biomed Res Int       Date:  2015-08-27       Impact factor: 3.411

Review 10.  The challenge of translating ischemic conditioning from animal models to humans: the role of comorbidities.

Authors:  Kieran McCafferty; Suzanne Forbes; Christoph Thiemermann; Muhammad M Yaqoob
Journal:  Dis Model Mech       Date:  2014-12       Impact factor: 5.758

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.